The International Advisory Committee on Clinical Trials led a multinational panel updating the McDonald criteria, adding the ...

MS causes the body to attack myelin, the protective membrane around nerve cells, causing debilitating symptoms such as ...

Sleep disorders are highly prevalent among individuals with multiple sclerosis (MS), affecting nearly half of the patient population, according to study results presented at the European Committee for ...

Patients with primary progressive MS more commonly exhibited delays in overall disability progression following treatment with ocrelizumab vs placebo.

Doctors believe they are ‘on the brink of a new class of treatments’ for MS - The MS Society said trial results are exciting ...